Arcellx

Medical Science Liaison (Carolinas)

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Medical Science Liaison (MSL)

Position Overview

Arcellx is seeking a highly motivated Medical Science Liaison (MSL) to join our field-based medical team. Reporting to the MSL National Field Director, you will serve as a key scientific resource and expert on cell therapy for healthcare professionals (HCPs) and internal stakeholders. Your role will be crucial in facilitating relationships with thought leaders, engaging in external-facing medical education, and collecting insights through scientific exchange to support the success of Arcellx's transformative therapy.

Who We Are

Arcellx is a public, clinical-stage biotechnology company dedicated to reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. We believe cell therapies are a cornerstone of future medicine and are committed to developing safer, more effective, and broadly accessible cell therapies to destroy cancer and advance humanity. Our team comprises talented innovators working across our Rockville, Maryland, and Redwood City, California offices. We foster a fun, diverse, supportive, and informal environment where exceptional people can do their best work.

What Matters to Us

At Arcellx, we live by our core values to maintain a high-performing, inclusive, and collaborative work environment. We seek candidates who align with these values and bring diverse backgrounds, viewpoints, and abilities to our team.

Arcellx Core Values

  • Start with authenticity: We foster an inclusive environment where each person can bring their authentic self to work.
  • Think ‘we’ before ‘me’: We prioritize collective success, collaborating and supporting one another to achieve our shared goals.
  • Embrace the challenge: We deliver exceptional results by working with shared determination and a commitment to doing what’s right.

Responsibilities

  • Establish and maintain professional relationships with HCPs (MD, PA, NP, RN, PharmD) within the hematology space via both in-person and virtual interactions.
  • Develop and execute territory plans in alignment with Medical Affairs strategies, including interactions with community thought leaders, disease state experts, cell therapy-referring HCPs, and academic centers.
  • Compliantly partner with field-based teams to optimize HCP support and customer service.
  • Deliver approved medical and scientific education relevant to the disease state and Arcellx products.
  • Share insights from external thought leaders and HCPs to inform the development of medical strategies and future clinical programs.
  • Represent Arcellx at medical and scientific conferences.
  • Partner with clinical operations to support the execution of clinical trials.
  • Domestic travel of approximately 50-70% will be required.

Requirements

  • Advanced degree in health sciences (PharmD, M.D., or Ph.D. in a medically related field) with 2+ years of relevant experience in the hematologic malignancy therapeutic area and/or cell therapy is preferred.
  • Master’s degree in health sciences (RN, RPh, PA, NP, etc.) will be considered if accompanied by extensive years of clinical and/or medical affairs experience in the relevant therapeutic area.
  • 2+ years of experience in MSL/Medical Affairs in a relevant therapeutic area. Experienced candidates may be considered at the senior level.
  • Familiarity/experience with healthcare systems and access environments.
  • Demonstrated ability to partner, influence, and work successfully within and across functions and leadership levels.
  • Excellent communication and presentation skills with strong personal integrity.
  • Agile, adaptable, and results-oriented.
  • Must reside within the designated territory.

Rewards at Arcellx

Our people are our greatest asset, and we are committed to supporting their well-being.

Employment Type:

[Employment Type Not Specified]

Location Type:

[Location Type Not Specified]

Salary:

[Salary Not Specified]

Skills

Cell Therapy
Medical Affairs
Scientific Exchange
Medical Education
Thought Leader Engagement
Insight Collection

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Gaithersburg, MarylandHeadquarters
2014Year Founded
$194.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Flexible Work Hours
401(k) Company Match
Fully-Paid Parental Leave
Tuition Reimbursement
Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI